Authors : Alshada Sharf; R. Divyadharshini; S. Gopal; V. Gowrishankar; P. Hemavathi; U. Suriya

Volume/Issue : Volume 11 - 2026, Issue 2 - February

Google Scholar : https://tinyurl.com/3ffbtn4p

Scribd : https://tinyurl.com/4tmezkxb

DOI : https://doi.org/10.38124/ijisrt/26feb1254

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : Particularly in primary care settings, digital health interventions have shown promise in enhancing medication adherence in patients with Type 2 Diabetes Mellitus (T2DM). A highly customized text and voice messaging intervention was assessed in a feasibility randomized controlled trial carried out in the UK to help patients with hypertension and/or type 2 diabetes take their medications as directed. Based on each person's beliefs, obstacles, and clinical traits, the intervention provided tailored behavioral support messages. Results showed that this type of customized digital communication is doable, patient-acceptable, and could enhance medication compliance and associated clinical outcomes in the treatment of chronic illnesses. The study also shown how individuals with type 2 diabetes can improve their self-management practices by incorporating theory-based behavioral approaches into mHealth platforms. When compared to conventional treatment, participants who received the intervention demonstrated increased engagement and good trends in adherence, suggesting that scalable digital messaging systems could improve long-term disease control. The study backs up the expanding importance of digital health technologies in routine primary care practice to enhance adherence and optimize outcomes for people with Type 2 Diabetes.

References :

1. World Health Organization. Global report on diabetes. Geneva: WHO; 2016.
2. Jimmy B, Jose J. Patient medication adherence: measures in daily practice. Oman Med J. 2011;26(3):155–159.
3. Nieuwlaat R, Wilczynski N, Navarro T, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014;11:CD000011.
4. World Health Organization. WHO guideline: recommendations on digital interventions for health system strengthening. Geneva: WHO; 2019.
5. McManus RJ, Mant J, Franssen M, Nickless A, Schwartz C, Hodgkinson J, et al. Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial. Lancet. 2018 Mar 10;391(10124):949-959.doi:10.1016/S0140-6736(18)30309-X.
6. Can Hou, Carter B, Hewitt J, Francisa T, Mayor S. Do mobile phone applications improve glycemic control (HbA1c) in the self-management of diabetes? A systematic review, meta-analysis, and GRADE of 14 randomized trials. Diabetes Care. 2016 Nov;39(11):2089–2095. doi:10.2337/dc16-0346.
7. Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705.
8. Sabaté E. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.
9. Polonsky WH, Henry RR. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adherence. 2016;10:1299–1307.
10. Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166(17):1836–1841.
11. Kassavou A, et al. A highly tailored text and voice messaging intervention to improve medication adherence in hypertension and type 2 diabetes: feasibility randomized controlled trial. J Med Internet Res. 2020;22(5):e16629. doi:10.2196/16629.
12. KD,et al. Impact of a diabetes remote monitoring program on medication adherence. J Manag Care Spec Pharm. 2021 Jun;27(6):724-731. doi:10.18553/jmcp.2021.27.6.724.
13. Effectiveness of a Digital Health Application for the Treatment of Diabetes Type II—A Pilot Study. J Clin Med. 2023;12(19):6317.
14. Nkhoma DE, Soko CJ, Banda KJ, Greenfield D, Iqbal U, et al. Impact of DSMES app interventions on medication adherence in type 2 diabetes mellitus: systematic review and meta-analysis. BMJ Health Care Inform. 2021 Apr;28(1):e100291. doi:10.1136/bmjhci-2020-100291.
15. World Health Organization. Global strategy on digital health 2020–2025. Geneva: World Health Organization; 2021.
16. Thakkar J, Kurup R, Laba TL, et al. Mobile telephone text messaging for medication adherence in chronic disease: a meta-analysis. JAMA Intern Med. 2016;176(3):340–349.
17. Lee SWH, Ooi L, Lai YK. Telemedicine for the management of glycemic control in patients with type 2 diabetes: systematic review and meta-analysis. J Med Internet Res. 2017;19(8):e275.
18. Kebede MM, Zeeb H, Peters M, Heise TL, Pischke CR. Effectiveness of digital interventions for improving glycemic control in persons with poorly controlled type 2 diabetes: a systematic review, meta-analysis, and meta-regression analysis. Diabetes Technol Ther. 2018;20(11):767-782. doi:10.1089/dia.2018.0216.
19. World Health Organization. mHealth: New horizons for health through mobile technologies. Geneva: World Health Organization; 2011.
20. Holmen H, Wahl AK, Cvancarova Småstuen M, et al. Tailored communication within mobile apps for diabetes self-management: a systematic review. J Med Internet Res. 2017;19(6):e227.
21. Bonoto BC, de Araújo VE, Godói IP, et al. Efficacy of mobile health interventions for diabetes treatment: systematic review and meta-analysis. JMIR Mhealth Uhealth. 2017;5(3):e4.
22. Marcolino MS, Oliveira JAQ, D’Agostino M, et al. The impact of mHealth interventions: systematic review of systematic reviews. JMIR Mhealth Uhealth. 2018;6(1):e23.
23. Tchero H, Kangambega P, Briatte C, Brunet-Houdard S, Retali GR, Rusch E. Clinical effectiveness of telemedicine in diabetes mellitus: a meta-analysis of 42 randomized controlled trials. Telemed J E Health. 2019;25(7):569–583.
24. Poudel A, Nissen LM. Telepharmacy: a pharmacist’s perspective on the clinical benefits and challenges.Integr Pharm Res Pract. 2016;5:75–82.
25. Odegard PS, Capoccia K. Medication taking and diabetes: a systematic review of the literature. Diabetes Educ. 2007;33(6):1014–1029.
26. Martínez-González NA, Berchtold P, Ullman K, Busato A, Egger M. Integrated care programmes for adults with chronic conditions: a meta-review. Int J Qual Health Care. 2014;26(5):561–570.
27. Kruse CS, Krowski N, Rodriguez B, Tran L, Vela J, Brooks M. Telehealth and patient satisfaction: a systematic review and narrative analysis. BMJ Open. 2017;7(8):e016242.
28. Dobson R, et al. Diabetes text-message self-management support program (SMS4BG): a pilot study. JMIR Mhealth Uhealth. 2015;3(1):e32. doi:10.2196/mhealth.3988.
29. Marcolino MS, Maia JX, Alkmim MBM, et al. Telemedicine application in the care of diabetes patients: systematic review and meta-analysis. PLoS One. 2013;8(11):e79246.
30. Kruse CS, Mileski M, Moreno J. Mobile health solutions for the aging population: a systematic narrative analysis. J Telemed Telecare. 2017;23(4):439–451.
31. Kruse CS, Frederick B, Jacobson T, Monticone DK. Cybersecurity in healthcare: a systematic review of modern threats and trends. Technol Health Care. 2017;25(1):1–10.
32. Gagnon MP, et al. m-Health adoption by healthcare professionals: a systematic review. J Am Med Inform Assoc. 2016;23(1):212–220. doi:10.1093/jamia/oc